Bennett C Frank's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Mar 5, 2026
- Accession no.
- 0000874015-26-000134
- Filed
- Mar 5, 2026
- Trade date
- Mar 3, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.74M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bennett C FrankCIK 0001073387 | Officer (EVP, Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | MOption exerciseAcquired | +16,463 | $32.60 | +$536,693.8 | 117,017 | Direct | |
| Mar 3, 2026 | Common Stock | MOption exerciseAcquired | +48,626 | $60.89 | +$2,960,837.14 | 165,643 | Direct | |
| Mar 3, 2026 | Common Stock | SSaleDisposed | −71,600 | $79.10 | −$5,663,560 | 94,043 | Direct | |
| Mar 3, 2026 | Common Stock | SSaleDisposed | −12,687 | $79.88 | −$1,013,437.56 | 81,356 | Direct | |
| Mar 3, 2026 | Common Stock | SSaleDisposed | −802 | $80.76 | −$64,769.52 | 80,554 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | MOption exerciseDisposed | −16,463 | $0.00 | $0 | 2,406 | Direct | |
| Mar 3, 2026 | Common Stock | MOption exerciseDisposed | −48,626 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.